A report released by the American Legacy Foundation says that American youth continue to show strong preferences for specific cigarette types, many of which are heavily marketed.
Roche’s second multinational phase III study provides further evidence of the significant role of IL-6 receptor inhibition in the treatment of rheumatoid arthritis.
The U.S. Department of Health and Human Services (HHS) has awarded a contract to Bavarian Nordic for the manufacture and delivery of 20 million doses of the company?s MVA based smallpox vaccine, IMVAMUNE?, for the protection of persons considered to be at risk for smallpox.
Nutrition 21, Inc. (NASDAQ: NXXI) announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome?, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
Researchers at the University of Alberta (Edmonton, AB) and Cortex Pharmaceuticals (Irvine, CA) believe that AMPAKINE drugs may provide protection from drug-induced respiratory depression, while simultaneously allowing the sedative or analgesic to continue working as it was intended.
Every year, tens of thousands of men and women from every county of Michigan and around the country turn to the University of Michigan Health System for advanced care for heart disease, blood vessel disorders and strokes. The number of visits for that care has nearly doubled in the last decade.
As the global public health community observes World No Tobacco Day, the American Legacy Foundation again calls attention to the health epidemic that tobacco causes for our nation.
454 Life Sciences Corporation of US would be able to give mapping of one’s genome in $10,000, however the genome of James Watson is the first to be sequenced for less than $1 million.
Dey, L.P. announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) of its marketing partner, Critical Therapeutics, Inc. (Nasdaq: CRTX), for ZYFLO CR? (zileuton) extended-release tablets.
Roche today announced the agreement of two new technology transfers with local manufacturing companies in Africa — Addis Pharmaceutical Factory in Ethiopia and Varichem Pharmaceuticals in Zimbabwe.